tive or easier to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. Certain matters discussed in this news release are forward-looking statements involving certain risks and uncertainties including, without limitation, risks detailed in the Company's Securities and Exchange Commission filings and reports.
For more information on GeoVax Labs, Inc., please visit the Company's website at www.geovax.com
'/>"/>SOURCE GeoVax Labs, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related biology technology :1.
GeoVax Labs, Inc. Announces Resignation of Director2.
GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois3.
GeoVax to Exhibit at the 2009 BIO International Convention4.
GeoVax Labs, Inc. Announces First Quarter Financial Results5.
GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results6.
GeoVax Update Provided at the BIO CEO & Investor Conference 20097.
GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference8.
GeoVax to Present at the BIO CEO & Investor Conference 20099.
GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update10.
GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial11.
GeoVax Presents Data at AIDS Vaccine 2008 Conference